EGFR and cancer: To broadly substantiate AXL expression with drug response to EGFR-TKIs, we examined the relationship of drug IC50 values with AXL expression in silico through an open-access application that mined the GDSC and Cancer Cell Line Encyclopedia (CCLE) data sets20.